Health Screening And Health Promotion Programs - NCLEX-PN

Early detection of disease or risk to enable timely intervention. Focuses on identifying asymptomatic individuals at risk, allowing for early interventions that improve outcomes and reduce disease burden.

Preventing disease before it occurs (risk reduction, immunization). Aims to eliminate or mitigate risk factors in healthy individuals, preventing the onset of disease through lifestyle changes and vaccinations.

Early detection and treatment to halt progression. Involves screening and early management to identify and treat conditions in asymptomatic stages, preventing advancement to severe disease.

Reducing complications and restoring function (rehabilitation). Focuses on managing existing chronic conditions to minimize impairments, enhance quality of life, and prevent further deterioration.

Actions that increase well-being and support healthy behaviors. Encompasses strategies beyond prevention to empower individuals and communities in adopting lifestyles that optimize physical, mental, and social health.

Obtain informed consent and explain purpose and next steps. Ensures ethical practice by respecting patient autonomy, providing necessary information, and preparing for potential outcomes to build trust.

Assess beliefs and literacy; adapt materials and method accordingly. Promotes effective communication by tailoring education to cultural contexts and health literacy levels, enhancing understanding and adherence.

Teach-back with correct return demonstration or explanation. Confirms comprehension and retention, allowing nurses to identify and correct misunderstandings for better health outcomes.

Ensure prompt referral and follow-up for diagnostic evaluation. Facilitates timely diagnostic confirmation and treatment, preventing delays that could worsen prognosis in potentially serious conditions.

Blood pressure measurement to detect hypertension early. Serves as secondary prevention by identifying asymptomatic hypertension, enabling early lifestyle or medical interventions to prevent complications.

Immunization clinic and smoking cessation counseling. Exemplifies primary prevention by addressing risk factors and building immunity before disease exposure occurs in the population.

Cardiac rehabilitation to reduce disability after myocardial infarction. Illustrates tertiary prevention by focusing on recovery and function restoration post-event to limit long-term disability and recurrence.

Elevated blood pressure. Classified per American Heart Association guidelines as elevated, indicating need for lifestyle modifications to prevent progression to hypertension.

Increased risk (>$40$ inches in men). Surpasses the guideline threshold, signaling elevated visceral fat and associated metabolic risks needing assessment and management.

PHQ-2 screening followed by PHQ-9 if positive. Recommended by USPSTF as an efficient initial tool, with follow-up for deeper assessment to guide appropriate mental health interventions.

Hypertension (Stage 2). Defined by guidelines as stage 2 hypertension, requiring prompt medical evaluation and potential pharmacologic intervention.

Obesity (Class I). Falls within 30-34.9 range per WHO classification, associated with moderate health risks requiring weight management strategies.

Screening identifies risk; diagnosis confirms disease. Screening targets apparently healthy populations for potential issues, while diagnostic testing investigates symptoms or positive screens to establish a definitive diagnosis.

Initiate safety precautions and notify provider immediately. Prioritizes patient safety by implementing immediate protective measures and escalating to professionals for crisis intervention.

Begin regular screening at age $45$ years. Based on USPSTF guidelines to detect precancerous lesions or early cancer in average-risk individuals, improving survival rates through timely treatment.

Pap test every $3$ years. Follows USPSTF recommendations for detecting precancerous changes in younger women, balancing benefits with risks of overtesting.

Primary HPV every $5$ years or Pap every $3$ years. Aligns with USPSTF options emphasizing HPV testing for higher sensitivity in detecting high-risk types, optimizing detection while minimizing procedures.

High community immunity reduces disease spread to vulnerable people. Achieved when vaccination rates create a protective barrier, indirectly safeguarding those unable to be vaccinated from infectious diseases.